Andrew COOK,John HAMILTON,Adrian ACHUTHAN,Derek LACEY
申请号：
US14916141
公开号：
US20160200808A1
申请日:
2014.09.02
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A protocol for pain management includes a pharmaceutical composition and its use in ameliorating the sensation of pain. The protocol includes the use of a CCL17 signaling antagonist alone or in combination with another analgesic compound to treat pain associated with inflammatory conditions. The CCL17 signaling antagonist includes an antibody or antigen-binding derivative thereof which binds to CCL17 or its receptor.
